PAG
LUMO

Paladin Advisory Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Paladin Advisory Group’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,387
Closed -$15.8K – 531
2022
Q4 		$15.8K Buy
4,387
+5
+0.1% +$33 0.01% 206
2022
Q3 		$38K Hold
4,382
– – 0.03% 173
2022
Q2 		$33K Buy
+4,382
New +$35.1K 0.03% 184
2022
Q1 		– Sell
-4,382
Closed -$30K – 552
2021
Q4 		$30K Buy
+4,382
New +$36.8K 0.02% 202

Paladin Advisory Group's LUMO Position: Q4 2024 in Review

Paladin Advisory Group sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2024, closing a stake of 4,387 shares — an estimated $17K sold.

Paladin Advisory Group first reported a position in LUMO in Q1 2022 and held it in 8 quarters. The position peaked at $40K in Q1 2022. 0 funds tracked by Wall St. Rank hold LUMO as of Q4 2024.

  • Paladin Advisory Group reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Paladin Advisory Group sold 4,387 Lumos Pharma, Inc. Common Stock shares in Q4 2024, an estimated $17K.
  • Paladin Advisory Group first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2022 and held it in 8 quarters.
  • Paladin Advisory Group's Lumos Pharma, Inc. Common Stock position peaked at $40K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2024.

Based on Paladin Advisory Group's 13F filing for Q4 2024, filed 23 Jan 2025.